Insider Trading activities of Satsuma Pharmaceuticals, Inc. (STSA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Satsuma Pharmaceuticals, Inc. (STSA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Satsuma Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Satsuma Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is STSA. The reporting company's CIK number is 1692830.
The total value of stock buying since 2005 is $44,999,985.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Satsuma Pharmaceuticals, Inc. (STSA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-09 2,999,999 $44,999,985 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Satsuma Pharmaceuticals, Inc. insiders (STSA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-09-17 Takanashi Ken (Director) Buy 233,333 15.00 3,499,995
2019-09-17 Shah Rajeev M. (Director) Buy 1,333,333 15.00 19,999,995
2019-09-17 Kolchinsky Peter Buy 1,333,333 15.00 19,999,995
2019-09-17 Coulter James G Buy 100,000 15.00 1,500,000

Insider trading activities including stock purchases, stock sales, and option exercises of STSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Satsuma Pharmaceuticals, Inc. (symbol STSA, CIK number 1692830) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month